Cargando…
Antihypertensive Drug Guanabenz Is Active In Vivo against both Yeast and Mammalian Prions
BACKGROUND: Prion-based diseases are incurable transmissible neurodegenerative disorders affecting animals and humans. METHODOLOGY/PRINCIPAL FINDINGS: Here we report the discovery of the in vivo antiprion activity of Guanabenz (GA), an agonist of α2-adrenergic receptors routinely used in human medic...
Autores principales: | Tribouillard-Tanvier, Déborah, Béringue, Vincent, Desban, Nathalie, Gug, Fabienne, Bach, Stéphane, Voisset, Cécile, Galons, Hervé, Laude, Hubert, Vilette, Didier, Blondel, Marc |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2291559/ https://www.ncbi.nlm.nih.gov/pubmed/18431471 http://dx.doi.org/10.1371/journal.pone.0001981 |
Ejemplares similares
-
Protein Folding Activity of Ribosomal RNA Is a Selective Target of Two Unrelated Antiprion Drugs
por: Tribouillard-Tanvier, Déborah, et al.
Publicado: (2008) -
Antiprion drugs 6-aminophenanthridine and guanabenz reduce PABPN1 toxicity and aggregation in oculopharyngeal muscular dystrophy
por: Barbezier, Nicolas, et al.
Publicado: (2011) -
The Toll-Like Receptor Agonist Imiquimod Is Active against Prions
por: Oumata, Nassima, et al.
Publicado: (2013) -
Glycoform-independent prion conversion by highly efficient, cell-based, protein misfolding cyclic amplification
por: Moudjou, Mohammed, et al.
Publicado: (2016) -
Transmission of Atypical Bovine Prions to Mice Transgenic for Human Prion Protein
por: Béringue, Vincent, et al.
Publicado: (2008)